A Prospective Study of the Clinical Outcome Following Treatment Discontinuation After Remission in First-Episode Schizophrenia
Phase of Trial: Phase IV
Latest Information Update: 10 Jun 2014
At a glance
- Drugs Risperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Janssen-Cilag
- 09 Feb 2012 Actual initiation date changed from Apr 2006 to Mar 2006 as reported by ClinicalTrials.gov.
- 09 Feb 2012 Trial phase changed from IV to III as reported by ClinicalTrials.gov.
- 11 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.